Navidea biopharmaceuticals announces business update call and changes to board of directors composition

Dublin, ohio--(business wire)--navidea biopharmaceuticals, inc. (nyse american: navb) (“navidea” or the “company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced a conference call to provide updates and discuss strategy, as well as the resignation of thomas farb and agnieszka winkler as members of the company's board of directors (the “board”), effective december 5, 2021. the company will hold the conference call and webcast on
NAVB Ratings Summary
NAVB Quant Ranking